Watchlist Price Alert

XOMA Corporation (XOMA)

NASDAQ: XOMA · Real-Time Price · USD

24.13

0.28 (1.17%)

At close: Jun 16, 2025, 3:59 PM

24.27

0.58%

After-hours: Jun 16, 2025, 04:01 PM EDT

1.17% (1D)

Bid	23
Market Cap	288.76M
Revenue (ttm)	36.54M
Net Income (ttm)	-2.86M
EPS (ttm)	-0.73
PE Ratio (ttm)	-33.05
Forward PE	76.34
Analyst	Buy

Ask	24.65
Volume	8,957
Avg. Volume (20D)	32,525
Open	23.99
Previous Close	23.85
Day's Range	23.98 - 24.55
52-Week Range	18.35 - 35.00
Beta	0.94

About XOMA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol XOMA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for XOMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

6 months ago

-3.05%

XOMA Royalty shares are trading higher after the c... Unlock content with Pro Subscription

News

1 month ago · zacks.com

XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates

XOMA Royalty (XOMA) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.26 per share. This compares to loss of $0.86 per share a year ago.

2 months ago · accessnewswire.com

BioInvent Receives Milestone Payment as Takeda moves mezagitamab into Phase 3

LUND, SWEDEN / ACCESS Newswire / April 8, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-clas...

2 months ago · seekingalpha.com

XOMA Royalty Corporation's Preferreds Still Offer Attractive Yields With A Biotech Twist

XOMA aggregates future biotech royalties and milestone rights for stable, diversified revenue streams. However, I believe its preferred shares (under tickers XOMAO and XOMAP) offer attractive yields w...